Portage Biotech Stock Market Value
| PRTG Stock | USD 4.87 0.15 3.18% |
| Symbol | Portage |
Portage Biotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 24.4 | Return On Assets (0.19) | Return On Equity (1.91) |
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Portage Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Portage Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Portage Biotech.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Portage Biotech on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Portage Biotech or generate 0.0% return on investment in Portage Biotech over 30 days. Portage Biotech is related to or competes with Amylyx Pharmaceuticals, Blueprint Medicines, Arvinas, Aerovate Therapeutics, Eliem Therapeutics, Anebulo Pharmaceuticals, and Cue Biopharma. Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products More
Portage Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Portage Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Portage Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.72 | |||
| Information Ratio | 0.0296 | |||
| Maximum Drawdown | 134.05 | |||
| Value At Risk | (14.59) | |||
| Potential Upside | 10.92 |
Portage Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Portage Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Portage Biotech's standard deviation. In reality, there are many statistical measures that can use Portage Biotech historical prices to predict the future Portage Biotech's volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.7717 | |||
| Total Risk Alpha | (2.11) | |||
| Sortino Ratio | 0.0482 | |||
| Treynor Ratio | (0.57) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Portage Biotech Backtested Returns
Portage Biotech is dangerous given 3 months investment horizon. Portage Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0645, which implies the firm had a 0.0645% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.11% are justified by taking the suggested risk. Use Portage Biotech Risk Adjusted Performance of 0.0379, semi deviation of 9.9, and Coefficient Of Variation of 2696.13 to evaluate company specific risk that cannot be diversified away. Portage Biotech holds a performance score of 5 on a scale of zero to a hundred. The company holds a Beta of -1.12, which implies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Portage Biotech are expected to decrease slowly. On the other hand, during market turmoil, Portage Biotech is expected to outperform it slightly. Use Portage Biotech potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Portage Biotech.
Auto-correlation | -0.88 |
Excellent reverse predictability
Portage Biotech has excellent reverse predictability. Overlapping area represents the amount of predictability between Portage Biotech time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Portage Biotech price movement. The serial correlation of -0.88 indicates that approximately 88.0% of current Portage Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.88 | |
| Spearman Rank Test | -0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Portage Biotech lagged returns against current returns
Autocorrelation, which is Portage Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Portage Biotech's stock expected returns. We can calculate the autocorrelation of Portage Biotech returns to help us make a trade decision. For example, suppose you find that Portage Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Portage Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Portage Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Portage Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Portage Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Portage Biotech Lagged Returns
When evaluating Portage Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Portage Biotech stock have on its future price. Portage Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Portage Biotech autocorrelation shows the relationship between Portage Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Portage Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Portage Biotech is a strong investment it is important to analyze Portage Biotech's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Portage Biotech's future performance. For an informed investment choice regarding Portage Stock, refer to the following important reports:Check out Portage Biotech Correlation, Portage Biotech Volatility and Portage Biotech Alpha and Beta module to complement your research on Portage Biotech. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.